Effects of Drug Loading on the Antitumor Activity of a Monoclonal Antibody Drug ConjugateKevin J. Hamblett, Joseph A. Francisco, Peter D. Senter et al.|Clinical Cancer Research|2004Cited by 1.2k
Development of potent monoclonal antibody auristatin conjugates for cancer therapySvetlana O. Doronina, Peter D. Senter, Brian E. Toki et al.|Nature Biotechnology|2003Cited by 1.2k
Arming antibodies: prospects and challenges for immunoconjugatesAnna M. Wu, Peter D. Senter|Nature Biotechnology|2005Cited by 1k
cAC10-vcMMAE, an anti-CD30–monomethyl auristatin E conjugate with potent and selective antitumor activityJoseph A. Francisco, Alan F. Wahl, Charles G. Cerveny et al.|Blood|2003Cited by 918
Antibody–drug conjugates come of age in oncologyCharles Dumontet, Alain Beck, Janice M. Reichert et al.|Nature Reviews Drug Discovery|2023Cited by 772